Full Transcript Is Vaginal Estrogen Safe After Breast Cancer? 0:01 Vaginal estrogen is one of the 0:01 is one of the 0:01 is one of the most effective and 0:02 most effective and 0:02 most effective and least 0:03 least 0:03 least used 0:03 used 0:04 used treatments in 0:04 treatments in 0:05 treatments in women's 0:05 women's 0:05 women's hormonal 0:06 hormonal 0:06 hormonal health. Most 0:07 health. Most 0:07 health. Most women avoid it 0:08 women avoid it 0:08 women avoid it because of fears that 0:09 because of fears that 0:09 because of fears that modern research 0:10 modern research 0:10 modern research simply no longer 0:11 simply no longer 0:11 simply no longer supports. 0:12 supports. 0:15 Today I'll explain what 0:17 the science really shows, including data 0:17 the science really shows, including data on those who have beaten 0:19 on those who have beaten 0:19 on those who have beaten breast cancer. 0:20 breast cancer. 0:23 Welcome to 0:23 Welcome to my channel. I am Dr. 0:24 my channel. I am Dr. 0:24 my channel. I am Dr. Elizabeth Tatakin, a 0:25 Elizabeth Tatakin, a 0:25 Elizabeth Tatakin, a naturopathic doctor, 0:26 naturopathic doctor, 0:26 naturopathic doctor, practicing in Arizona 0:27 practicing in Arizona 0:27 practicing in Arizona and consulting 0:28 and consulting 0:28 and consulting nationally and 0:29 nationally and 0:29 nationally and internationally. 0:31 internationally. 0:31 internationally. I work with women 0:32 I work with women 0:32 I work with women throughout their 0:33 throughout their 0:33 throughout their lives, 0:34 lives, 0:34 lives, focusing on 0:35 focusing on 0:35 focusing on premenopause, 0:36 premenopause, 0:36 premenopause, menopause, and the 0:36 menopause, and the 0:36 menopause, and the hormonal 0:37 hormonal 0:37 hormonal transitions that 0:38 transitions that 0:38 transitions that accompany them. Before 0:40 accompany them. Before 0:40 accompany them. Before we continue, 0:41 we continue, 0:41 we continue, one important 0:42 one important 0:42 one important note. This video 0:44 note. This video 0:44 note. This video contains educational 0:45 contains educational 0:45 contains educational information and is not 0:46 information and is not 0:46 information and is not medical advice for 0:47 medical advice for 0:47 medical advice for your specific 0:48 your specific 0:48 your specific situation. Therefore, 0:50 situation. Therefore, 0:50 situation. Therefore, please consult 0:51 please consult 0:51 please consult your doctor. That said 0:52 your doctor. That said 0:52 your doctor. That said , I regularly 0:53 , I regularly 0:53 , I regularly prescribe 0:54 prescribe 0:54 prescribe vaginal estrogen 0:55 vaginal estrogen 0:55 vaginal estrogen in my practice. This is 0:57 in my practice. This is 0:57 in my practice. This is one of the 0:57 one of the 0:57 one of the most useful, 0:58 most useful, 0:58 most useful, effective, and 0:59 effective, and 0:59 effective, and least 0:59 least 0:59 least discussed 1:00 discussed 1:00 discussed tools I 1:01 tools I 1:01 tools I use with pre- 1:02 use with pre- 1:05 and post-menopausal women. By the end of 1:05 and post-menopausal women. By the end of this video, you'll 1:06 this video, you'll 1:06 this video, you'll learn how it 1:07 learn how it 1:07 learn how it differs from 1:08 differs from 1:08 differs from systemic 1:09 systemic 1:09 systemic hormone therapy 1:10 hormone therapy , what the safety 1:11 , what the safety 1:11 , what the safety data actually shows, 1:12 data actually shows, 1:12 data actually shows, and who 1:13 and who 1:16 benefits the most. Let's start with what 1:16 benefits the most. Let's start with what exactly we are
What Is Genitourinary Syndrome of Menopause? 1:18 exactly we are 1:18 exactly we are talking about. Starting in 1:20 talking about. Starting in 1:20 talking about. Starting in premenopause, when 1:21 premenopause, when 1:21 premenopause, when estrogen levels 1:22 estrogen levels 1:22 estrogen levels begin to decline, 1:24 begin to decline, 1:24 begin to decline, the tissues of the vagina, vulva, 1:25 the tissues of the vagina, vulva, 1:25 the tissues of the vagina, vulva, and bladder 1:26 and bladder 1:26 and bladder begin 1:27 begin 1:27 begin to change. They 1:28 to change. They 1:28 to change. They become thinner, 1:29 become thinner, 1:29 become thinner, drier, and less 1:30 drier, and less 1:30 drier, and less elastic. 1:32 elastic. 1:32 elastic. There is a name for this. This 1:33 There is a name for this. This 1:33 There is a name for this. This is called 1:34 is called 1:34 is called genitourinary 1:35 genitourinary 1:35 genitourinary syndrome of menopause, 1:37 syndrome of menopause, 1:37 syndrome of menopause, or GUSM. The symptoms are 1:40 or GUSM. The symptoms are 1:40 or GUSM. The symptoms are very diverse, and 1:41 very diverse, and 1:41 very diverse, and many women do 1:42 many women do 1:42 many women do not associate them with 1:44 not associate them with 1:44 not associate them with hormones at all. 1:44 hormones at all. 1:46 Vaginal dryness, 1:46 Vaginal dryness, thinning and 1:47 thinning and 1:47 thinning and irritation, 1:48 irritation, 1:48 irritation, discomfort or 1:49 discomfort or 1:49 discomfort or painful intercourse, 1:50 painful intercourse, 1:50 painful intercourse, burning or itching, 1:52 burning or itching, 1:52 burning or itching, more frequent 1:53 more frequent 1:53 more frequent urinary tract infections, an 1:54 urinary tract infections, an 1:54 urinary tract infections, an urgent urge 1:55 urgent urge 1:55 urgent urge to urinate, that 1:57 to urinate, that 1:57 to urinate, that sudden feeling that 1:58 sudden feeling that 1:58 sudden feeling that you need to go, and 1:59 you need to go, and 1:59 you need to go, and general 2:01 general 2:01 general bladder discomfort. 2:02 bladder discomfort. 2:02 bladder discomfort. Here's what's important 2:03 Here's what's important 2:03 Here's what's important to understand. Hot flashes 2:06 to understand. Hot flashes 2:06 to understand. Hot flashes usually 2:07 usually 2:07 usually go away on their own over time, 2:09 go away on their own over time, 2:09 go away on their own over time, but GUSM does not, because 2:10 but GUSM does not, because 2:10 but GUSM does not, because it is caused by a 2:11 it is caused by a 2:11 it is caused by a constant 2:12 constant 2:12 constant lack of 2:13 lack of 2:13 lack of estrogen in these 2:14 estrogen in these 2:14 estrogen in these tissues. Without 2:15 tissues. Without 2:15 tissues. Without treatment, it 2:16 treatment, it 2:17 treatment, it tends to gradually 2:18 tends to gradually 2:18 tends to gradually worsen rather than 2:19 worsen rather than 2:19 worsen rather than improve. And this is a 2:20 improve. And this is a 2:20 improve. And this is a common phenomenon. By 2:22 common phenomenon. By 2:22 common phenomenon. By some estimates, 2:23 some estimates, 2:23 some estimates, about half of 2:24 about half of 2:26 postmenopausal women 2:26 postmenopausal women experience symptoms of 2:27 experience symptoms of 2:27 experience symptoms of GUSM. However, most 2:30 GUSM. However, most 2:30 GUSM. However, most never mention 2:31 never mention 2:31 never mention it, and many are 2:32 it, and many are 2:32 it, and many are never asked 2:33 never asked . This is not a cosmetic 2:35 . This is not a cosmetic 2:35 . This is not a cosmetic problem or a matter of 2:36 problem or a matter of 2:36 problem or a matter of vanity. This 2:37 vanity. This 2:37 vanity. This affects sleep, 2:38 affects sleep, 2:38 affects sleep, comfort, intimate 2:39 comfort, intimate 2:39 comfort, intimate life, relationships, and 2:40 life, relationships, and 2:40 life, relationships, and 2:42 urinary tract health. 2:42 urinary tract health. This deserves to be 2:44 This deserves to be 2:44 This deserves to be treated as the 2:44 treated as the 2:44 treated as the medical condition that 2:46 medical condition that 2:46 medical condition that it is. The reason 2:47 it is. The reason 2:47 it is. The reason so many women 2:48 so many women 2:48 so many women go 2:49 go 2:49 go untreated comes down 2:51 untreated comes down 2:51 untreated comes down to one thing—fear 2:52 to one thing—fear 2:52 to one thing—fear of estrogen. And 2:54 of estrogen. And 2:54 of estrogen. And this fear 2:55 this fear 2:55 this fear stems from a 2:56 stems from a 2:56 stems from a difference that has 2:57 difference that has 2:59 never been clearly 2:59 never been clearly explained to most women. So, 3:01 explained to most women. So, 3:01 explained to most women. So, let's explain this.
Vaginal Estrogen vs Systemic Hormone Therapy 3:02 let's explain this. 3:05 When most people 3:05 When most people hear about 3:06 hear about 3:06 hear about hormone therapy, 3:07 hormone therapy, 3:07 hormone therapy, they imagine 3:08 they imagine 3:08 they imagine systemic HRT, which is 3:09 systemic HRT, which is 3:09 systemic HRT, which is estrogen in pills, 3:10 estrogen in pills, 3:10 estrogen in pills, patches, or creams 3:12 patches, or creams 3:12 patches, or creams that is absorbed into the 3:13 that is absorbed into the 3:13 that is absorbed into the bloodstream and distributed throughout the 3:14 bloodstream and distributed throughout the 3:14 bloodstream and distributed throughout the body. It 3:17 body. It 3:17 body. It reaches the brain, heart, 3:18 reaches the brain, heart, 3:18 reaches the brain, heart, breast tissue 3:19 breast tissue 3:19 breast tissue , and the entire 3:20 , and the entire 3:20 , and the entire body. This is the 3:23 body. This is the 3:23 body. This is the form that requires a more 3:24 form that requires a more 3:24 form that requires a more complex conversation 3:25 complex conversation 3:25 complex conversation about risks and benefits 3:26 about risks and benefits , and it is what the 3:27 , and it is what the 3:27 , and it is what the old 3:28 old 3:28 old headlines were about. 3:29 headlines were about. 3:32 Vaginal estrogen is a completely different thing. 3:34 is a completely different thing. 3:36 This is a very low dose 3:36 This is a very low dose that is applied 3:37 that is applied 3:37 that is applied directly to the 3:38 directly to the 3:38 directly to the tissues of the vagina and 3:39 tissues of the vagina and 3:39 tissues of the vagina and vulva, where it acts 3:40 vulva, where it acts 3:40 vulva, where it acts locally. The amount 3:42 locally. The amount 3:42 locally. The amount that enters the 3:43 that enters the 3:43 that enters the bloodstream is minimal. 3:44 bloodstream is minimal. 3:45 bloodstream is minimal. In women 3:46 In women 3:46 In women using 3:47 using 3:47 using low doses of 3:47 low doses of 3:47 low doses of vaginal 3:48 vaginal 3:48 vaginal estrogen, 3:49 estrogen, 3:49 estrogen, blood estrogen levels 3:50 blood estrogen levels 3:50 blood estrogen levels usually remain 3:51 usually remain 3:51 usually remain within the normal range for 3:52 within the normal range for 3:52 within the normal range for postmenopausal women 3:53 postmenopausal women 3:53 postmenopausal women . Here's an 3:54 . Here's an 3:54 . Here's an analogy I 3:55 analogy I 3:55 analogy I use with 3:56 use with 3:56 use with patients. 3:57 patients. 3:57 patients. Systemic hormone 3:59 Systemic hormone 3:59 Systemic hormone therapy is like 4:00 therapy is like 4:00 therapy is like turning on the heating in the 4:01 turning on the heating in the 4:01 turning on the heating in the whole house. 4:02 whole house. 4:05 Vaginal estrogen is like a heating pad for 4:06 is like a heating pad for 4:06 is like a heating pad for one room. The effect 4:09 one room. The effect 4:09 one room. The effect stays where 4:11 stays where 4:11 stays where it is needed and does not 4:12 it is needed and does not 4:12 it is needed and does not heat up the entire 4:12 heat up the entire 4:12 heat up the entire system, as it does 4:13 system, as it does 4:13 system, as it does not significantly increase 4:15 not significantly increase 4:15 not significantly increase estrogen levels in the 4:16 estrogen levels in the 4:16 estrogen levels in the rest of the body. It does not 4:20 rest of the body. It does not 4:20 rest of the body. It does not carry the same 4:21 carry the same 4:21 carry the same cardiovascular risks 4:22 cardiovascular risks as 4:23 as 4:23 as oral 4:24 oral 4:24 oral hormone therapy. 4:25 hormone therapy. 4:29 It also bypasses what is 4:29 It also bypasses what is called primary 4:30 called primary 4:30 called primary metabolism in the liver. 4:31 metabolism in the liver. 4:32 metabolism in the liver. Therefore, a very small dose is 4:33 Therefore, a very small dose is 4:33 Therefore, a very small dose is sufficient to 4:34 sufficient to 4:34 sufficient to do the job 4:35 do the job 4:35 do the job locally. This 4:37 locally. This 4:37 locally. This mechanism is key, 4:38 mechanism is key, 4:38 mechanism is key, and it brings us
What Does the Breast Cancer Research Show? 4:39 and it brings us 4:39 and it brings us to the question that 4:40 to the question that 4:40 to the question that most 4:41 most 4:41 most women are here for. What about 4:43 women are here for. What about 4:43 women are here for. What about breast cancer? 4:45 breast cancer? 4:45 breast cancer? It's fear that 4:46 It's fear that 4:46 It's fear that keeps women from getting 4:47 keeps women from getting 4:47 keeps women from getting treatment that could 4:49 treatment that could 4:49 treatment that could really help them. 4:50 really help them. 4:51 really help them. So, let's 4:51 So, let's 4:51 So, let's see what the 4:52 see what the 4:54 research actually says. The 4:55 research actually says. The most recent and 4:56 most recent and 4:56 most recent and largest analysis on 4:57 largest analysis on 4:57 largest analysis on this topic was 4:58 this topic was 4:58 this topic was published in 5:00 published in 5:00 published in 2025. It combined seven 5:03 2025. It combined seven 5:03 2025. It combined seven studies and more than 5:04 studies and more than 5:04 studies and more than 118,000 women who 5:05 118,000 women who 5:05 118,000 women who had 5:06 had 5:06 had breast cancer. 5:08 breast cancer. 5:08 breast cancer. Women who 5:09 Women who 5:09 Women who used 5:09 used 5:09 used vaginal estrogen did 5:11 vaginal estrogen did not have a higher 5:12 not have a higher 5:12 not have a higher rate of 5:13 rate of 5:13 rate of breast cancer coming back. The 5:14 breast cancer coming back. The 5:16 recurrence rate did not 5:16 recurrence rate did not increase, and 5:18 increase, and 5:18 increase, and breast cancer mortality 5:19 breast cancer mortality 5:19 breast cancer mortality was not higher. A 5:20 was not higher. A 5:23 previous review in 2024 5:23 previous review in 2024 reached the same 5:24 reached the same 5:25 reached the same general conclusion. 5:26 general conclusion. 5:27 general conclusion. Think about this for a moment. 5:28 Think about this for a moment. 5:31 In the group with the greatest 5:31 In the group with the greatest reason for 5:32 reason for 5:32 reason for caution—women 5:33 caution—women 5:33 caution—women who already had 5:34 who already had 5:34 who already had breast cancer— 5:35 breast cancer— 5:35 breast cancer— the data did not show that 5:36 the data did not show that 5:36 the data did not show that low-dose 5:37 low-dose 5:37 low-dose vaginal 5:38 vaginal 5:38 vaginal estrogen 5:38 estrogen 5:38 estrogen worsened 5:39 worsened 5:39 worsened outcomes. Now I 5:42 outcomes. Now I 5:42 outcomes. Now I want to be honest with 5:43 want to be honest with 5:43 want to be honest with you, because that's how I
Vaginal Estrogen and Aromatase Inhibitors 5:44 you, because that's how I 5:44 you, because that's how I practice. There is one 5:46 practice. There is one 5:46 practice. There is one group where the situation is 5:47 group where the situation is 5:47 group where the situation is less clear-cut. For 5:50 less clear-cut. For 5:50 less clear-cut. For women taking a 5:51 women taking a 5:51 women taking a class of drugs 5:52 class of drugs 5:52 class of drugs called 5:53 called 5:53 called 5:54 aromatase inhibitors, which are 5:54 aromatase inhibitors, which are used for 5:56 used for 5:56 used for some types of 5:56 some types of 5:57 some types of estrogen-positive 5:58 estrogen-positive 5:58 estrogen-positive breast cancer, 5:59 breast cancer, 5:59 breast cancer, the evidence is more 6:00 the evidence is more 6:00 the evidence is more conflicting. Several 6:02 conflicting. Several 6:02 conflicting. Several analyses have raised 6:03 analyses have raised 6:03 analyses have raised the question of 6:03 the question of 6:04 the question of recurrence, which has 6:05 recurrence, which has 6:05 recurrence, which has not yet been 6:05 not yet been 6:05 not yet been definitively answered 6:07 definitively answered . If this applies to 6:09 . If this applies to 6:09 . If this applies to you, discuss this 6:10 you, discuss this 6:10 you, discuss this directly with 6:11 directly with 6:11 directly with your oncologist and a 6:12 your oncologist and a 6:13 your oncologist and a doctor 6:13 doctor 6:13 doctor specializing in 6:14 specializing in 6:14 specializing in menopause. This is not a 6:17 menopause. This is not a 6:17 menopause. This is not a decision that should be 6:18 decision that should be 6:18 decision that should be made after 6:19 made after 6:19 made after watching a video, and I would 6:20 watching a video, and I would 6:20 watching a video, and I would never want to do it 6:21 never want to do it . But for most 6:25 . But for most 6:25 . But for most women, the fear of 6:26 women, the fear of 6:26 women, the fear of vaginal 6:26 vaginal 6:26 vaginal estrogen arises 6:27 estrogen arises 6:27 estrogen arises because the 6:28 because the 6:29 because the risk profile of systemic 6:29 risk profile of systemic 6:30 risk profile of systemic hormone therapy 6:31 hormone therapy 6:31 hormone therapy is being transferred to a 6:32 is being transferred to a 6:32 is being transferred to a product that simply 6:33 product that simply 6:33 product that simply does not work in the body in 6:34 does not work in the body in 6:34 does not work in the body in this way. If this 6:39 this way. If this 6:39 this way. If this helped you 6:40 helped you 6:40 helped you understand 6:41 understand 6:41 understand vaginal 6:42 vaginal 6:42 vaginal estrogen, 6:42 estrogen, 6:42 estrogen, leave a comment 6:43 leave a comment 6:43 leave a comment below. I'm curious 6:47 below. I'm curious 6:47 below. I'm curious to know if this is a topic 6:48 to know if this is a topic 6:48 to know if this is a topic you were afraid 6:49 you were afraid 6:49 you were afraid to ask about. And if it 6:52 to ask about. And if it 6:52 to ask about. And if it became clearer to you, 6:53 became clearer to you, 6:53 became clearer to you, subscribe. This 6:55 subscribe. This 6:56 subscribe. This channel is dedicated to 6:57 channel is dedicated to 6:57 channel is dedicated to naturopathic and 6:58 naturopathic and 6:58 naturopathic and functional 6:59 functional 6:59 functional medicine in the field of 6:59 medicine in the field of 7:00 medicine in the field of women's and 7:00 women's and 7:00 women's and family health. 7:01 family health. 7:02 family health. Now I'm going to go into detail about 7:03 Now I'm going to go into detail about 7:03 Now I'm going to go into detail about 7:05 premenopause and 7:05 premenopause and menopause. You won't 7:06 menopause. You won't 7:06 menopause. You won't want to miss what 7:07 want to miss what 7:07 want to miss what comes next. So, 7:08 comes next. So, 7:08 comes next. So, who is this really for 7:10 who is this really for ? Let's look at 7:11 ? Let's look at 7:11 ? Let's look at the range of applications, 7:12 the range of applications, 7:12 the range of applications, because it is wider than 7:13 because it is wider than 7:13 because it is wider than many
Who Can Benefit From Vaginal Estrogen? 7:14 many 7:14 many women think. First, 7:15 women think. First, 7:15 women think. First, vaginal dryness 7:16 vaginal dryness 7:16 vaginal dryness and atrophy. This is the 7:17 and atrophy. This is the 7:17 and atrophy. This is the most well-known 7:18 most well-known 7:18 most well-known use case 7:19 use case . Low-dose 7:21 . Low-dose 7:21 . Low-dose vaginal estrogen 7:22 vaginal estrogen 7:22 vaginal estrogen restores tissue thickness and 7:23 restores tissue thickness and 7:23 restores tissue thickness and hydration, and 7:24 hydration, and 7:24 hydration, and the changes can be 7:25 the changes can be 7:25 the changes can be dramatic. Secondly, 7:28 dramatic. Secondly, 7:28 dramatic. Secondly, pain during 7:29 pain during 7:29 pain during sexual intercourse. When 7:32 sexual intercourse. When 7:32 sexual intercourse. When pain is caused by 7:33 pain is caused by 7:33 pain is caused by thinning of dry 7:34 thinning of dry 7:34 thinning of dry tissues, restoring 7:35 tissues, restoring 7:35 tissues, restoring them to health in 7:36 them to health in 7:37 them to health in most cases 7:38 most cases 7:38 most cases eliminates the pain. 7:39 eliminates the pain. 7:42 Women who have 7:42 Women who have avoided intimacy for years 7:44 avoided intimacy for years 7:44 avoided intimacy for years sometimes reclaim this 7:45 sometimes reclaim this 7:45 sometimes reclaim this part of their lives. 7:47 part of their lives. Third, and this is 7:48 Third, and this is 7:48 Third, and this is most often 7:49 most often 7:49 most often overlooked, are 7:50 overlooked, are 7:50 overlooked, are recurrent 7:51 recurrent 7:51 recurrent urinary tract infections. 7:52 urinary tract infections. 7:55 When the tissues of the vagina and 7:55 When the tissues of the vagina and urethra lose 7:56 urethra lose 7:56 urethra lose estrogen, they also 7:57 estrogen, they also 7:57 estrogen, they also lose some of their 7:59 lose some of their 7:59 lose some of their protective barrier and 8:00 protective barrier and 8:00 protective barrier and healthy microflora. 8:01 healthy microflora. 8:04 Therefore, restoring 8:04 Therefore, restoring local estrogen 8:06 local estrogen 8:06 local estrogen restores this 8:07 restores this 8:07 restores this protection and can significantly 8:08 protection and can significantly 8:08 protection and can significantly reduce the incidence of 8:09 reduce the incidence of 8:09 reduce the incidence of infections in 8:10 infections in 8:10 infections in postmenopausal women. If 8:13 postmenopausal women. If 8:13 postmenopausal women. If you feel like you 8:14 you feel like you 8:14 you feel like you 're taking 8:15 're taking 8:15 're taking antibiotics every 8:16 antibiotics every 8:16 antibiotics every few months, it's worth 8:17 few months, it's worth 8:17 few months, it's worth asking about it. 8:18 asking about it. Fourth, urge to 8:19 Fourth, urge to 8:19 Fourth, urge to urinate and 8:20 urinate and 8:22 bladder symptoms. The 8:22 bladder symptoms. The bladder and 8:23 bladder and 8:23 bladder and urethra also have 8:24 urethra also have 8:24 urethra also have estrogen receptors. 8:26 estrogen receptors. 8:26 estrogen receptors. For many women, 8:27 For many women, 8:27 For many women, restoring 8:28 restoring 8:28 restoring local estrogen 8:29 local estrogen 8:29 local estrogen calms these urges 8:31 calms these urges 8:31 calms these urges and improves 8:32 and improves 8:32 and improves bladder function. And 8:33 bladder function. And 8:33 bladder function. And finally, the physical 8:34 finally, the physical 8:35 finally, the physical aspect of sexual 8:36 aspect of sexual 8:36 aspect of sexual function. By reducing 8:37 function. By reducing 8:37 function. By reducing pain and restoring 8:38 pain and restoring 8:39 pain and restoring tissue sensitivity, 8:40 tissue sensitivity, 8:40 tissue sensitivity, vaginal estrogen 8:41 vaginal estrogen 8:41 vaginal estrogen can improve the 8:42 can improve the 8:42 can improve the physical sensation 8:43 physical sensation 8:43 physical sensation during sex. This is 8:45 during sex. This is 8:45 during sex. This is related to libido. 8:46 related to libido. 8:49 Although libido itself is a 8:49 Although libido itself is a broader topic with many 8:50 broader topic with many 8:50 broader topic with many aspects, and I will make a 8:52 aspects, and I will make a 8:52 aspects, and I will make a separate video about it. 8:53 separate video about it. 8:54 separate video about it. So, let's get to the 8:55 So, let's get to the 8:55 So, let's get to the practice. If you 8:56 practice. If you 8:56 practice. If you think this might be right for 8:58 think this might be right for 8:58 think this might be right for you, here's what you 8:59 you, here's what you 8:59 you, here's what you should know. 9:00 should know.
Vaginal Estrogen Options and How to Ask Your Doctor 9:02 Vaginal estrogen 9:02 Vaginal estrogen comes in several 9:03 comes in several 9:03 comes in several forms, and they all 9:04 forms, and they all 9:04 forms, and they all work 9:05 work 9:05 work by delivering this 9:06 by delivering this 9:06 by delivering this low dose. There is a cream, there is a 9:08 low dose. There is a cream, there is a 9:08 low dose. There is a cream, there is a small tablet 9:10 small tablet 9:10 small tablet or insert. There is a soft 9:12 or insert. There is a soft 9:12 or insert. There is a soft ring that 9:13 ring that 9:13 ring that is inserted and 9:14 is inserted and 9:14 is inserted and slowly releases 9:15 slowly releases 9:15 slowly releases estrogen for 9:17 estrogen for 9:17 estrogen for about 3 months, as 9:18 about 3 months, as 9:18 about 3 months, as well as suppositories. The choice 9:21 well as suppositories. The choice 9:21 well as suppositories. The choice depends on 9:21 depends on 9:21 depends on personal preference 9:23 personal preference 9:23 personal preference and what is more convenient for you 9:24 and what is more convenient for you 9:24 and what is more convenient for you . There is also a 9:26 . There is also a 9:26 . There is also a non-estrogenic 9:27 non-estrogenic 9:27 non-estrogenic option 9:28 option 9:28 option worth knowing about— 9:29 worth knowing about— vaginal DHEA. This is a 9:33 vaginal DHEA. This is a 9:33 vaginal DHEA. This is a precursor that your 9:34 precursor that your 9:34 precursor that your body 9:35 body 9:35 body converts locally into 9:36 converts locally into 9:36 converts locally into small amounts of 9:37 small amounts of 9:37 small amounts of estrogen and 9:37 estrogen and 9:38 estrogen and testosterone right in the 9:39 testosterone right in the 9:39 testosterone right in the tissues. For women 9:41 tissues. For women 9:41 tissues. For women who prefer 9:43 who prefer 9:43 who prefer to avoid the word " 9:44 to avoid the word " estrogen" altogether, this is another 9:45 estrogen" altogether, this is another 9:45 estrogen" altogether, this is another path to the same goal. 9:46 path to the same goal. 9:48 So, how do you 9:48 So, how do you start a conversation about this? 9:49 start a conversation about this? 9:50 start a conversation about this? Keep your 9:50 Keep your 9:50 Keep your wording simple. You 9:52 wording simple. You 9:52 wording simple. You might say, “ 9:53 might say, “ 9:53 might say, “ I have vaginal 9:54 I have vaginal 9:54 I have vaginal dryness, or frequent 9:55 dryness, or frequent 9:55 dryness, or frequent 9:57 urinary tract infections, 9:57 urinary tract infections, or discomfort during 9:58 or discomfort during 9:58 or discomfort during intercourse, and 9:59 intercourse, and 9:59 intercourse, and I would like to discuss 10:00 I would like to discuss whether 10:01 whether 10:01 whether low-dose 10:02 low-dose 10:02 low-dose vaginal estrogen would be right for me 10:04 vaginal estrogen would be right for me .” This one phrase 10:06 .” This one phrase 10:06 .” This one phrase opens the door. And one more thing 10:08 opens the door. And one more thing 10:08 opens the door. And one more thing : unlike 10:09 : unlike 10:09 : unlike systemic 10:10 systemic 10:10 systemic hormone therapy 10:11 hormone therapy , which involves 10:12 , which involves 10:12 , which involves talking about when and 10:13 talking about when and 10:14 talking about when and whether to stop it 10:15 whether to stop it , vaginal 10:16 , vaginal 10:16 , vaginal estrogen 10:17 estrogen 10:17 estrogen can usually be used for 10:18 can usually be used for 10:18 can usually be used for a long time. This is a 10:20 a long time. This is a 10:20 a long time. This is a treatment for local 10:21 treatment for local 10:21 treatment for local changes that do not 10:22 changes that do not 10:22 changes that do not go away on their own. 10:23 go away on their own. 10:23 go away on their own. Therefore, if treatment is stopped 10:24 Therefore, if treatment is stopped 10:24 Therefore, if treatment is stopped , symptoms 10:25 , symptoms 10:26 , symptoms usually 10:26 usually 10:26 usually return. And the 10:27 return. And the 10:28 return. And the regulatory framework is 10:29 regulatory framework is 10:29 regulatory framework is now catching up with 10:30 now catching up with 10:30 now catching up with scientific data. The FDA 10:34 scientific data. The FDA 10:34 scientific data. The FDA recently updated 10:35 recently updated 10:35 recently updated the labeling for these 10:36 the labeling for these 10:36 the labeling for these products, removing 10:37 products, removing 10:37 products, removing the most stringent 10:38 the most stringent 10:38 the most stringent warning from 10:39 warning from 10:39 warning from low-dose 10:40 low-dose 10:40 low-dose vaginal 10:41 vaginal 10:41 vaginal estrogen, recognizing 10:42 estrogen, recognizing 10:42 estrogen, recognizing that its systemic 10:43 that its systemic 10:43 that its systemic absorption and 10:44 absorption and 10:44 absorption and risks are 10:45 risks are 10:45 risks are minimal. This is where 10:48 minimal. This is where 10:50 one of the principles that 10:51 one of the principles that I follow in 10:52 I follow in 10:52 I follow in practice comes in handy. In 10:53 practice comes in handy. In 10:53 practice comes in handy. In naturopathic 10:54 naturopathic 10:54 naturopathic medicine, one of our 10:55 medicine, one of our 10:55 medicine, one of our oldest ideas is "the 10:56 oldest ideas is "the doctor as teacher." 10:58 doctor as teacher." 10:58 doctor as teacher." My job here is 10:59 My job here is 10:59 My job here is not to 11:00 not to 11:00 not to make decisions for 11:01 make decisions for 11:01 make decisions for you. And it's about 11:02 you. And it's about 11:02 you. And it's about providing you with 11:03 providing you with 11:03 providing you with information so you 11:04 information so you 11:04 information so you can come to your 11:05 can come to your 11:05 can come to your appointment and build a 11:07 appointment and build a 11:07 appointment and build a better dialogue. So, 11:09 better dialogue. So, 11:09 better dialogue. So, let's summarize. 11:10 let's summarize. 11:10 let's summarize. Vaginal estrogen is 11:11 Vaginal estrogen is not what 11:13 not what 11:13 not what many women 11:14 many women 11:14 many women think of it. It 11:15 think of it. It 11:15 think of it. It is not systemic. This is not the same 11:17 is not systemic. This is not the same 11:17 is not systemic. This is not the same hormone therapy 11:18 hormone therapy 11:18 hormone therapy that caused all the 11:19 that caused all the 11:19 that caused all the controversy 11:20 controversy 11:20 controversy a decade ago. This is a 11:23 a decade ago. This is a 11:24 a decade ago. This is a targeted, 11:24 targeted, 11:24 targeted, low-dose 11:25 low-dose 11:25 low-dose topical treatment for a 11:26 topical treatment for a 11:26 topical treatment for a condition that affects 11:27 condition that affects 11:27 condition that affects about half of 11:28 about half of 11:28 about half of all 11:29 all 11:29 all postmenopausal women. Three 11:32 postmenopausal women. Three 11:32 postmenopausal women. Three things to 11:33 things to 11:33 things to remember. First: 11:34 remember. First: 11:34 remember. First: vaginal estrogen 11:35 vaginal estrogen 11:35 vaginal estrogen has minimal 11:36 has minimal 11:36 has minimal systemic 11:37 systemic 11:37 systemic absorption. It is 11:38 absorption. It is 11:38 absorption. It is fundamentally 11:39 fundamentally 11:39 fundamentally different from 11:40 different from 11:40 different from systemic 11:40 systemic 11:40 systemic hormone therapy 11:42 hormone therapy . Second: Recent 11:46 . Second: Recent 11:46 . Second: Recent data among over 100,000 11:47 data among over 100,000 11:50 breast cancer survivors found that 11:50 breast cancer survivors found that vaginal estrogen did 11:51 vaginal estrogen did 11:51 vaginal estrogen did not increase the risk 11:53 not increase the risk 11:55 of cancer recurrence or death, 11:55 of cancer recurrence or death, except in the case of 11:56 except in the case of 11:56 except in the case of 11:58 aromatase inhibitors, which is worth 11:58 aromatase inhibitors, which is worth discussing with your 11:59 discussing with your 11:59 discussing with your oncologist. Third: 12:03 oncologist. Third: 12:03 oncologist. Third: The problems it 12:04 The problems it 12:05 The problems it treats—dryness, pain 12:06 treats—dryness, pain 12:06 treats—dryness, pain during 12:07 during 12:07 during intercourse, frequent 12:08 intercourse, frequent 12:08 intercourse, frequent urinary tract infections, 12:10 urinary tract infections, 12:10 urinary tract infections, and the urge to 12:10 and the urge to 12:10 and the urge to urinate—are 12:11 urinate—are 12:11 urinate—are serious medical 12:13 serious medical 12:13 serious medical issues, and they don't 12:14 issues, and they don't 12:14 issues, and they don't go away on their own. 12:15 go away on their own. 12:17 In naturopathic 12:17 In naturopathic medicine, we talk 12:19 medicine, we talk 12:19 medicine, we talk about removing 12:19 about removing 12:19 about removing obstacles to 12:20 obstacles to 12:20 obstacles to healing and giving the 12:21 healing and giving the 12:21 healing and giving the body what it 12:22 body what it 12:22 body what it needs. Sometimes 12:24 needs. Sometimes 12:24 needs. Sometimes this obstacle is 12:26 this obstacle is 12:26 this obstacle is inflammation or 12:26 inflammation or 12:26 inflammation or nutrient deficiencies 12:28 nutrient deficiencies 12:28 nutrient deficiencies . And sometimes it's 12:30 . And sometimes it's 12:30 . And sometimes it's simply a lack of the 12:31 simply a lack of the 12:31 simply a lack of the hormone in the tissue 12:32 hormone in the tissue 12:32 hormone in the tissue that 12:33 that 12:33 that depends on it. Your 12:34 depends on it. Your 12:34 depends on it. Your body knows how to 12:35 body knows how to 12:35 body knows how to heal itself. My role is 12:37 heal itself. My role is to help remove what gets in the way 12:38 to help remove what gets in the way 12:38 to help remove what gets in the way . 12:39 . 12:40 . If decreased libido 12:41 If decreased libido 12:41 If decreased libido is part of your 12:42 is part of your 12:43 is part of your situation, and it often 12:44 situation, and it often 12:44 situation, and it often accompanies the changes 12:45 accompanies the changes 12:45 accompanies the changes we talked about 12:46 we talked about 12:46 we talked about today, I will make a 12:47 today, I will make a 12:47 today, I will make a separate video on 12:49 separate video on 12:49 separate video on what actually 12:50 what actually 12:50 what actually causes it and what the 12:50 causes it and what the 12:50 causes it and what the 12:54 evidence supports. I will prepare 12:54 evidence supports. I will prepare it as soon as possible. 12:55 it as soon as possible. 12:56 it as soon as possible. And here is your next 12:57 And here is your next 12:57 And here is your next step. The conversation 12:58 step. The conversation 12:58 step. The conversation starts at 12:59 starts at 12:59 starts at your next 13:00 your next 13:00 your next appointment. Name 13:02 appointment. Name 13:02 appointment. Name the symptoms out loud. 13:03 the symptoms out loud. 13:03 the symptoms out loud. Ask about 13:04 Ask about 13:04 Ask about topical 13:05 topical 13:05 topical estrogen options. And if your 13:08 estrogen options. And if your 13:08 estrogen options. And if your doctor is not familiar with the 13:10 doctor is not familiar with the 13:10 doctor is not familiar with the current evidence, it is 13:11 current evidence, it is 13:11 current evidence, it is entirely appropriate 13:12 entirely appropriate 13:12 entirely appropriate to ask for a 13:12 to ask for a 13:12 to ask for a referral to a 13:13 referral to a 13:13 referral to a menopause specialist. 13:14 menopause specialist. 13:18 If you are looking for clear 13:18 If you are looking for clear and up-to-date 13:19 and up-to-date 13:19 and up-to-date information about 13:20 information about 13:22 women's hormonal health, this channel is 13:22 women's hormonal health, this channel is for you. Subscribe 13:24 for you. Subscribe and see you in the 13:25 and see you in the 13:25 and see you in the next video.
Comments